{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T13:09:19Z","timestamp":1686402559079},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T00:00:00Z","timestamp":1442880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00277-015-2510-0","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T01:06:06Z","timestamp":1442883966000},"page":"87-92","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, l-asparaginase, and\/or methotrexate may improve the outcome of T-lineage ALL"],"prefix":"10.1007","volume":"95","author":[{"given":"Shinichi","family":"Kako","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Akahoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naonori","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Kameda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomotaka","family":"Ugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Ashizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiriko","family":"Terasako-Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-ichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misato","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakasone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junji","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"issue":"26","key":"2510_CR1","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1200\/JCO.2005.05.047","volume":"23","author":"SA Armstrong","year":"2005","unstructured":"Armstrong SA, Look AT (2005) Molecular genetics of acute lymphoblastic leukemia. J Clin Oncol 23(26):6306\u201315. doi: 10.1200\/JCO.2005.05.047","journal-title":"J Clin Oncol"},{"key":"2510_CR2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1182\/asheducation.V2012.1.389.3798360","volume":"2012","author":"CG Mullighan","year":"2012","unstructured":"Mullighan CG (2012) The molecular genetic makeup of acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2012:389\u201396. doi: 10.1182\/asheducation-2012.1.389","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"2510_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0889-8588(02)00004-7","volume":"16","author":"RS Riley","year":"2002","unstructured":"Riley RS, Massey D, Jackson-Cook C, Idowu M, Romagnoli G (2002) Immunophenotypic analysis of acute lymphocytic leukemia. Hematol Oncol Clin North Am 16(2):245\u201399, v","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"2510_CR4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1182\/blood.V84.5.1603.1603","volume":"84","author":"C Boucheix","year":"1994","unstructured":"Boucheix C, David B, Sebban C, Racadot E, Bene MC, Bernard A, Campos L, Jouault H, Sigaux F, Lepage E et al (1994) Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters, and outcome: an analysis of a prospective trial including 562 tested patients (LALA87). French Group on Therapy for Adult Acute Lymphoblastic Leukemia. Blood 84(5):1603\u201312","journal-title":"Blood"},{"issue":"11","key":"2510_CR5","first-page":"3931","volume":"93","author":"MS Czuczman","year":"1999","unstructured":"Czuczman MS, Dodge RK, Stewart CC, Frankel SR, Davey FR, Powell BL, Szatrowski TP, Schiffer CA, Larson RA, Bloomfield CD (1999) Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: cancer and leukemia Group B study 8364. Blood 93(11):3931\u20139","journal-title":"Blood"},{"issue":"12","key":"2510_CR6","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1182\/blood-2005-04-1623","volume":"106","author":"JM Rowe","year":"2005","unstructured":"Rowe JM, Buck G, Burnett AK, Chopra R, Wiernik PH, Richards SM, Lazarus HM, Franklin IM, Litzow MR, Ciobanu N, Prentice HG, Durrant J, Tallman MS, Goldstone AH (2005) Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII\/ECOG E2993. Blood 106(12):3760\u20137","journal-title":"Blood"},{"issue":"5","key":"2510_CR7","first-page":"1556","volume":"92","author":"RA Larson","year":"1998","unstructured":"Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA (1998) A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 92(5):1556\u201364","journal-title":"Blood"},{"issue":"1","key":"2510_CR8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cncr.27617","volume":"119","author":"W Stock","year":"2013","unstructured":"Stock W, Johnson JL, Stone RM, Kolitz JE, Powell BL, Wetzler M, Westervelt P, Marcucci G, DeAngelo DJ, Vardiman JW, McDonnell D, Mrozek K, Bloomfield CD, Larson RA (2013) Dose intensification of daunorubicin and cytarabine during treatment of adult acute lymphoblastic leukemia: results of Cancer and Leukemia Group B Study 19802. Cancer 119(1):90\u20138. doi: 10.1002\/cncr.27617","journal-title":"Cancer"},{"issue":"10","key":"2510_CR9","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/sj.leu.2404785","volume":"21","author":"A Bajel","year":"2007","unstructured":"Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M (2007) Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol. Leukemia 21(10):2230\u20133. doi: 10.1038\/sj.leu.2404785","journal-title":"Leukemia"},{"issue":"2","key":"2510_CR10","first-page":"154","volume":"87","author":"JM Ribera","year":"2002","unstructured":"Ribera JM, Ortega JJ, Oriol A, Granada I, Hernandez-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, Gonzalez-Valentin ME, Moreno MJ, Besalduch J, Fernandez-Calvo J, Tormo M, Arias J, Molines A, Sanz MA, Maldonado J, Milla F, Feliu E, San Miguel JF (2002) Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial. Haematologica 87(2):154\u201366","journal-title":"Haematologica"},{"issue":"8","key":"2510_CR11","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1182\/blood.V85.8.2025.bloodjournal8582025","volume":"85","author":"RA Larson","year":"1995","unstructured":"Larson RA, Dodge RK, Burns CP, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR et al (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and leukemia group B study 8811. Blood 85(8):2025\u201337","journal-title":"Blood"},{"issue":"10","key":"2510_CR12","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1182\/blood-2003-10-3560","volume":"104","author":"M Hunault","year":"2004","unstructured":"Hunault M, Harousseau JL, Delain M, Truchan-Graczyk M, Cahn JY, Witz F, Lamy T, Pignon B, Jouet JP, Garidi R, Caillot D, Berthou C, Guyotat D, Sadoun A, Sotto JJ, Lioure B, Casassus P, Solal-Celigny P, Stalnikiewicz L, Audhuy B, Blanchet O, Baranger L, Bene MC, Ifrah N (2004) Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial. Blood 104(10):3028\u201337","journal-title":"Blood"},{"issue":"15","key":"2510_CR13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350(15):1535\u201348. doi: 10.1056\/NEJMra023001","journal-title":"N Engl J Med"},{"issue":"12","key":"2510_CR14","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1002\/cncr.20668","volume":"101","author":"H Kantarjian","year":"2004","unstructured":"Kantarjian H, Thomas D, O\u2019Brien S, Cortes J, Giles F, Jeha S, Bueso-Ramos CE, Pierce S, Shan J, Koller C, Beran M, Keating M, Freireich EJ (2004) Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia. Cancer 101(12):2788\u2013801","journal-title":"Cancer"},{"issue":"10","key":"2510_CR15","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.2002.07.116","volume":"20","author":"C Linker","year":"2002","unstructured":"Linker C, Damon L, Ries C, Navarro W (2002) Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia. J Clin Oncol 20(10):2464\u201371","journal-title":"J Clin Oncol"},{"issue":"6","key":"2510_CR16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Lafage-Pochitaloff M, Chassevent A, Lheritier V, Macintyre E, Bene MC, Ifrah N, Dombret H (2009) Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol 27(6):911\u20138","journal-title":"J Clin Oncol"},{"issue":"10","key":"2510_CR17","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2002-08-2454","volume":"101","author":"BC Bostrom","year":"2003","unstructured":"Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, Erdmann GR, Gold S, Heerema NA, Hutchinson RJ, Provisor AJ, Trigg ME (2003) Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group. Blood 101(10):3809\u201317. doi: 10.1182\/blood-2002-08-2454","journal-title":"Blood"},{"issue":"4","key":"2510_CR18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1200\/JCO.2001.19.4.1040","volume":"19","author":"CL Schwartz","year":"2001","unstructured":"Schwartz CL, Thompson EB, Gelber RD, Young ML, Chilton D, Cohen HJ, Sallan SE (2001) Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. J Clin Oncol 19(4):1040\u20136","journal-title":"J Clin Oncol"},{"issue":"10","key":"2510_CR19","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1182\/blood.V78.10.2514.2514","volume":"78","author":"CM Niemeyer","year":"1991","unstructured":"Niemeyer CM, Gelber RD, Tarbell NJ, Donnelly M, Clavell LA, Blattner SR, Donahue K, Cohen HJ, Sallan SE (1991) Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (protocol 81-01 update). Blood 78(10):2514\u20139","journal-title":"Blood"},{"issue":"5","key":"2510_CR20","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","volume":"97","author":"LB Silverman","year":"2001","unstructured":"Silverman LB, Gelber RD, Dalton VK, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Arkin S, Declerck L, Cohen HJ, Sallan SE (2001) Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood 97(5):1211\u20138","journal-title":"Blood"},{"issue":"9","key":"2510_CR21","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D et al (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84(9):3122\u201333","journal-title":"Blood"},{"issue":"3","key":"2510_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.leu.2401310","volume":"13","author":"MD Amylon","year":"1999","unstructured":"Amylon MD, Shuster J, Pullen J, Berard C, Link MP, Wharam M, Katz J, Yu A, Laver J, Ravindranath Y, Kurtzberg J, Desai S, Camitta B, Murphy SB (1999) Intensive high-dose asparaginase consolidation improves survival for pediatric patients with T cell acute lymphoblastic leukemia and advanced stage lymphoblastic lymphoma: a Pediatric Oncology Group study. Leukemia 13(3):335\u201342","journal-title":"Leukemia"},{"issue":"24","key":"2510_CR23","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MK Parmar","year":"1998","unstructured":"Parmar MK, Torri V, Stewart L (1998) Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17(24):2815\u201334","journal-title":"Stat Med"},{"issue":"3","key":"2510_CR24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48(3):452\u20138. doi: 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"issue":"Pt 1","key":"2510_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1348\/000711010X522687","volume":"64","author":"HM Huizenga","year":"2011","unstructured":"Huizenga HM, Visser I, Dolan CV (2011) Testing overall and moderator effects in random effects meta-regression. Br J Math Stat Psychol 64(Pt 1):1\u201319. doi: 10.1348\/000711010X522687","journal-title":"Br J Math Stat Psychol"},{"issue":"3","key":"2510_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0925-5710(98)00075-9","volume":"68","author":"T Ueda","year":"1998","unstructured":"Ueda T, Miyawaki S, Asou N, Kuraishi Y, Hiraoka A, Kuriyama K, Minami S, Ohshima T, Ino T, Tamura J, Kanamaru A, Nishikawa K, Tanimoto M, Oh H, Saito K, Nagata K, Naoe T, Yamada O, Urasaki Y, Sakura T, Ohno R (1998) Response-oriented individualized induction therapy with six drugs followed by four courses of intensive consolidation, 1\u00a0year maintenance and intensification therapy: the ALL90 study of the Japan Adult Leukemia Study Group. Int J Hematol 68(3):279\u201389","journal-title":"Int J Hematol"},{"issue":"9","key":"2510_CR27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1349-7006.2007.00556.x","volume":"98","author":"K Tobinai","year":"2007","unstructured":"Tobinai K, Takeyama K, Arima F, Aikawa K, Kobayashi T, Hanada S, Kasai M, Ogura M, Sueoka E, Mukai K, Tajima K, Fukuda H, Shirakawa S, Hotta T, Masanori S (2007) Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004. Cancer Sci 98(9):1350\u20137. doi: 10.1111\/j.1349-7006.2007.00556.x","journal-title":"Cancer Sci"},{"issue":"10","key":"2510_CR28","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1182\/blood-2006-09-045351","volume":"109","author":"M Wetzler","year":"2007","unstructured":"Wetzler M, Sanford BL, Kurtzberg J, DeOliveira D, Frankel SR, Powell BL, Kolitz JE, Bloomfield CD, Larson RA (2007) Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511. Blood 109(10):4164\u20137. doi: 10.1182\/blood-2006-09-045351","journal-title":"Blood"},{"issue":"3","key":"2510_CR29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s12185-010-0672-z","volume":"92","author":"I Jinnai","year":"2010","unstructured":"Jinnai I, Sakura T, Tsuzuki M, Maeda Y, Usui N, Kato M, Okumura H, Kyo T, Ueda Y, Kishimoto Y, Yagasaki F, Tsuboi K, Horiike S, Takeuchi J, Iwanaga M, Miyazaki Y, Miyawaki S, Ohnishi K, Naoe T, Ohno R (2010) Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study. Int J Hematol 92(3):490\u2013502","journal-title":"Int J Hematol"},{"issue":"5","key":"2510_CR30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jjco\/hys029","volume":"42","author":"T Azuma","year":"2012","unstructured":"Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mukai K, Tsukasaki K, Shimoyama M (2012) Phase II study of intensive post-remission chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia and lymphoblastic lymphoma: Japan Clinical Oncology Group Study, JCOG9402. Jpn J Clin Oncol 42(5):394\u2013404. doi: 10.1093\/jjco\/hys029","journal-title":"Jpn J Clin Oncol"},{"key":"2510_CR31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/asheducation-2011.1.231","volume":"2011","author":"AK Fielding","year":"2011","unstructured":"Fielding AK (2011) Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2011:231\u20137. doi: 10.1182\/asheducation-2011.1.231","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"2510_CR32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/asheducation-2010.1.21","volume":"2010","author":"W Stock","year":"2010","unstructured":"Stock W (2010) Adolescents and young adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2010:21\u20139. doi: 10.1182\/asheducation-2010.1.21","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2510-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-015-2510-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-015-2510-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T15:20:21Z","timestamp":1599578421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-015-2510-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["2510"],"URL":"https:\/\/doi.org\/10.1007\/s00277-015-2510-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]}}}